Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection. (September 2021)
- Record Type:
- Journal Article
- Title:
- Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection. (September 2021)
- Main Title:
- Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection
- Authors:
- Heer, Randeep S
Mandal, Amit KJ
Kho, Jason
Szawarski, Piotr
Csabi, Peter
Grenshaw, Dawn
Walker, Ian AL
Missouris, Constantinos G - Abstract:
- Background: The variability of Covid-19 severity between patients has driven efforts to identify prognosticating laboratory markers that could aid clinical decision-making. Procalcitonin is classically used as a diagnostic marker in bacterial infections, but its role in predicting Covid-19 disease severity is emerging. We aimed to identify the association between procalcitonin and Covid-19 disease severity in a critical care setting and whether bacterial co-infection is implicated. Methods: We retrospectively reviewed Covid-19 patients with procalcitonin concentrations measured in a critical care setting at our institution between February and September 2020. Laboratory markers including peak procalcitonin values and a range of bacterial culture results were analysed. Outcomes were the requirement and duration of invasive mechanical ventilation as well as inpatient mortality. Results: In total, 60 patients were included; 68% required invasive mechanical ventilation and 45% died as inpatient. Univariate analysis identified higher peak procalcitonin concentrations significantly associated with both the requirement for invasive mechanical ventilation (OR: 3.2, 95% CI 1.3–9.0, P = 0.02) and inpatient mortality (OR: 2.6, 95% CI 1.1–6.6, P = 0.03). Higher peak procalcitonin concentrations was an independent predictor of mortality on multivariate analysis (OR 3.7, 95% CI 1.1–12.4, P = 0.03). There was a significant positive correlation between increased peak procalcitoninBackground: The variability of Covid-19 severity between patients has driven efforts to identify prognosticating laboratory markers that could aid clinical decision-making. Procalcitonin is classically used as a diagnostic marker in bacterial infections, but its role in predicting Covid-19 disease severity is emerging. We aimed to identify the association between procalcitonin and Covid-19 disease severity in a critical care setting and whether bacterial co-infection is implicated. Methods: We retrospectively reviewed Covid-19 patients with procalcitonin concentrations measured in a critical care setting at our institution between February and September 2020. Laboratory markers including peak procalcitonin values and a range of bacterial culture results were analysed. Outcomes were the requirement and duration of invasive mechanical ventilation as well as inpatient mortality. Results: In total, 60 patients were included; 68% required invasive mechanical ventilation and 45% died as inpatient. Univariate analysis identified higher peak procalcitonin concentrations significantly associated with both the requirement for invasive mechanical ventilation (OR: 3.2, 95% CI 1.3–9.0, P = 0.02) and inpatient mortality (OR: 2.6, 95% CI 1.1–6.6, P = 0.03). Higher peak procalcitonin concentrations was an independent predictor of mortality on multivariate analysis (OR 3.7, 95% CI 1.1–12.4, P = 0.03). There was a significant positive correlation between increased peak procalcitonin concentrations and duration on invasive mechanical ventilation. No significant difference was found between peak procalcitonin concentrations of patients with positive and negative bacterial cultures. Conclusions: Elevated procalcitonin concentrations in Covid-19 patients are associated with respiratory failure requiring prolonged invasive mechanical ventilation and inpatient mortality. This association may be independent of bacterial co-infection. … (more)
- Is Part Of:
- Annals of clinical biochemistry. Volume 58:Number 5(2021)
- Journal:
- Annals of clinical biochemistry
- Issue:
- Volume 58:Number 5(2021)
- Issue Display:
- Volume 58, Issue 5 (2021)
- Year:
- 2021
- Volume:
- 58
- Issue:
- 5
- Issue Sort Value:
- 2021-0058-0005-0000
- Page Start:
- 520
- Page End:
- 527
- Publication Date:
- 2021-09
- Subjects:
- Procalcitonin -- Covid-19 -- ventilation -- mortality -- bacterial co-infection
Clinical chemistry -- Periodicals
Clinical biochemistry -- Periodicals
616.075 - Journal URLs:
- http://web.ebscohost.com/ehost/detail?sid=810a7788-77dd-439f-9630-ad7f5b199fd3%40sessionmgr4&vid=1&hid=14&bdata=JnNpdGU9ZWhvc3QtbGl2ZSZzY29wZT1zaXRl#db=mnh&jid=0324055 ↗
http://acb.rsmjournals.com ↗
http://www.usc.edu/hsc/nml/e-resources/info/annclib.html ↗
http://www.uk.sagepub.com/home.nav ↗
http://www.ingentaconnect.com/content/rsm/acb ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1177/00045632211022380 ↗
- Languages:
- English
- ISSNs:
- 0004-5632
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17122.xml